SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-19-001037
Filing Date
2019-02-26
Accepted
2019-02-26 07:01:53
Documents
110
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 20-F rdhl-20181231x20f.htm 20-F 3837738
2 EX-1.1 rdhl-20181231ex1144258b8.htm EX-1.1 276464
3 EX-4.10 rdhl-20181231ex410f5fd9a.htm EX-4.10 17348
4 EX-4.12 rdhl-20181231ex412db7a15.htm EX-4.12 25059
5 EX-4.14 rdhl-20181231ex41404f957.htm EX-4.14 72417
6 EX-4.15 rdhl-20181231ex415feb299.htm EX-4.15 39181
7 EX-4.2 rdhl-20181231ex42acc9ab7.htm EX-4.2 65108
8 EX-4.4 rdhl-20181231ex442e1ff8f.htm EX-4.4 50915
9 EX-4.6 rdhl-20181231ex467425fbf.htm EX-4.6 24159
10 EX-4.9 rdhl-20181231ex49f31305d.htm EX-4.9 28259
11 EX-12.1 rdhl-20181231ex121109c57.htm EX-12.1 15857
12 EX-12.2 rdhl-20181231ex1228f4bc2.htm EX-12.2 17404
13 EX-13 rdhl-20181231ex136a61564.htm EX-13 12698
14 EX-15.1 rdhl-20181231ex1516826d3.htm EX-15.1 6288
15 GRAPHIC rdhl20181231ex1516826d3001.jpg GRAPHIC 2374
16 GRAPHIC rdhl20181231x20f001.jpg GRAPHIC 1713
  Complete submission text file 0001558370-19-001037.txt   10989211

Data Files

Seq Description Document Type Size
17 EX-101.INS rdhl-20181231.xml EX-101.INS 2034471
18 EX-101.SCH rdhl-20181231.xsd EX-101.SCH 82621
19 EX-101.CAL rdhl-20181231_cal.xml EX-101.CAL 55533
20 EX-101.DEF rdhl-20181231_def.xml EX-101.DEF 176134
21 EX-101.LAB rdhl-20181231_lab.xml EX-101.LAB 548325
22 EX-101.PRE rdhl-20181231_pre.xml EX-101.PRE 391883
Mailing Address 21 HA'ARBA'A STREET TEL AVIV L3 64739
Business Address 21 HA'ARBA'A STREET TEL AVIV L3 64739 972-3-541-3131
RedHill Biopharma Ltd. (Filer) CIK: 0001553846 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3
Type: 20-F | Act: 34 | File No.: 001-35773 | Film No.: 19631610
SIC: 2834 Pharmaceutical Preparations